Norbert Oppitz — Management

Get alerts when Norbert Oppitz trades

Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: Swedish Orphan Biovitrum AB (publ).

12-month summary

Buying and selling balanced over the last 12 months

4 open-market buys, 3 sales, 1 share award · SEK 67,083,716.11 bought, SEK 72,631,823.35 sold

Roles

27.10.2025 – 28.07.2026

Transactions (including via associated entities)

DateIssuerTransaction typeVolumePriceValueSource
28.07.2026✎Swedish Orphan Biovitrum AB (publ) Stockholm
Bought — open marketAcquisition
66,702SEK 235.15
SEK 15,684,975.30
↗
24.07.2026Swedish Orphan Biovitrum AB (publ) Stockholm
SoldDisposal
66,702SEK 454.44
SEK 30,312,317.62
↗
24.07.2026Swedish Orphan Biovitrum AB (publ) Stockholm
Bought — open marketAcquisition
66,702SEK 454.44
SEK 30,312,317.62
↗
12.06.2026Swedish Orphan Biovitrum AB (publ) Stockholm
Share award
19,034—
Share award
19,034 shares
↗
05.05.2026Swedish Orphan Biovitrum AB (publ) Stockholm
SoldDisposal
12,000SEK 434.09
SEK 5,209,107.60
↗
29.10.2025✎Swedish Orphan Biovitrum AB (publ) Stockholm
Bought — open marketAcquisition
69,920SEK 208.11
SEK 14,551,051.20
↗
29.10.2025✎Swedish Orphan Biovitrum AB (publ) Stockholm
Bought — open marketAcquisition
44,723SEK 146.13
SEK 6,535,371.99
↗
27.10.2025✎Swedish Orphan Biovitrum AB (publ) Stockholm
SoldDisposal
114,643SEK 323.70
SEK 37,110,398.13
↗